PHARMACEUTICAL PREPARATIONS REDUCING OR

Brand Owner (click to sort) Address Description
REVACEL Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Third Floor Westlake Village CA 91362 Pharmaceutical preparations for reducing or removing localized fat. Pharmaceutical preparations for non-surgical removal of fat accumulation under the chin or sub-mental fat. Pharmaceutical preparations for non-surgical facial contouring or facial sculpting;
REVACYL Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Third Floor Westlake Village CA 91362 Pharmaceutical preparations for reducing or removing localized fat. Pharmaceutical preparations for non-surgical removal of fat accumulation under the chin or sub-mental fat. Pharmaceutical preparations for non-surgical facial contouring or facial sculpting;
REVASEL Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Third Floor Westlake Village CA 91362 Pharmaceutical preparations for reducing or removing localized fat. Pharmaceutical preparations for non-surgical removal of fat accumulation under the chin or sub-mental fat. Pharmaceutical preparations for non-surgical facial contouring or facial sculpting;
REVASYL Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Third Floor Westlake Village CA 91362 Pharmaceutical preparations for reducing or removing localized fat. Pharmaceutical preparations for non-surgical removal of fat accumulation under the chin or sub-mental fat. Pharmaceutical preparations for non-surgical facial contouring or facial sculpting;
REVICYL Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Third Floor Westlake Village CA 91362 Pharmaceutical preparations for reducing or removing localized fat. Pharmaceutical preparations for non-surgical removal of fat accumulation under the chin or sub-mental fat. Pharmaceutical preparations for non-surgical facial contouring or facial sculpting;
REVISYL Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Third Floor Westlake Village CA 91362 Pharmaceutical preparations for reducing or removing localized fat. Pharmaceutical preparations for non-surgical removal of fat accumulation under the chin or sub-mental fat. Pharmaceutical preparations for non-surgical facial contouring or facial sculpting;
REVYCYL Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Third Floor Westlake Village CA 91362 Pharmaceutical preparations for reducing or removing localized fat. Pharmaceutical preparations for non-surgical removal of fat accumulation under the chin or sub-mental fat. Pharmaceutical preparations for non-surgical facial contouring or facial sculpting;
REVYSYL Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Third Floor Westlake Village CA 91362 Pharmaceutical preparations for reducing or removing localized fat. Pharmaceutical preparations for non-surgical removal of fat accumulation under the chin or sub-mental fat. Pharmaceutical preparations for non-surgical facial contouring or facial sculpting;
REVYZEL Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Third Floor Westlake Village CA 91362 Pharmaceutical preparations for reducing or removing localized fat. Pharmaceutical preparations for non-surgical removal of fat accumulation under the chin or sub-mental fat. Pharmaceutical preparations for non-surgical facial contouring or facial sculpting;
REVYZELL Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Third Floor Westlake Village CA 91362 Pharmaceutical preparations for reducing or removing localized fat. Pharmaceutical preparations for non-surgical removal of fat accumulation under the chin or sub-mental fat. Pharmaceutical preparations for non-surgical facial contouring or facial sculpting;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.